Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia

NCT07223658 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

78

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperlipidemia; Mixed

Interventions

DRUG: ARO-DIMERPA
DRUG: Placebo

Sponsor

Arrowhead Pharmaceuticals